Rivera R - Search Results

1

A Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA₁), UCM-05194, Shows Efficacy in Neuropathic Pain Amelioration.

González-Gil I, Zian D, Vázquez-Villa H, Hernández-Torres G, Martínez RF, Khiar-Fernández N, Rivera R, Kihara Y, Devesa I, Mathivanan S, Del Valle CR, Zambrana-Infantes E, Puigdomenech M, Cincilla G, Sanchez-Martinez M, Rodríguez de Fonseca F, Ferrer-Montiel AV, Chun J, López-Vales R, López-Rodríguez ML, Ortega-Gutiérrez S. González-Gil I, et al. Among authors: rivera r. J Med Chem. 2020 Mar 12;63(5):2372-2390. doi: 10.1021/acs.jmedchem.9b01287. Epub 2019 Dec 16. J Med Chem. 2020. PMID: 31790581 Free PMC article.

2

GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5.

Lee CW, Rivera R, Gardell S, Dubin AE, Chun J. Lee CW, et al. Among authors: rivera r. J Biol Chem. 2006 Aug 18;281(33):23589-97. doi: 10.1074/jbc.M603670200. Epub 2006 Jun 14. J Biol Chem. 2006. PMID: 16774927 Free article.

3

LPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signaling and G(12/13)-mediated Rho activation.

Lee CW, Rivera R, Dubin AE, Chun J. Lee CW, et al. Among authors: rivera r. J Biol Chem. 2007 Feb 16;282(7):4310-4317. doi: 10.1074/jbc.M610826200. Epub 2006 Dec 13. J Biol Chem. 2007. PMID: 17166850 Free article.

4

Biological effects of lysophospholipids.

Rivera R, Chun J. Rivera R, et al. Rev Physiol Biochem Pharmacol. 2008;160:25-46. doi: 10.1007/112_0507. Rev Physiol Biochem Pharmacol. 2008. PMID: 18481029 Review.

5

Insights into the pharmacological relevance of lysophospholipid receptors.

Mutoh T, Rivera R, Chun J. Mutoh T, et al. Among authors: rivera r. Br J Pharmacol. 2012 Feb;165(4):829-44. doi: 10.1111/j.1476-5381.2011.01622.x. Br J Pharmacol. 2012. PMID: 21838759 Free PMC article. Review.

6

Lysophosphatidic acid signaling may initiate fetal hydrocephalus.

Yung YC, Mutoh T, Lin ME, Noguchi K, Rivera RR, Choi JW, Kingsbury MA, Chun J. Yung YC, et al. Among authors: rivera rr. Sci Transl Med. 2011 Sep 7;3(99):99ra87. doi: 10.1126/scitranslmed.3002095. Sci Transl Med. 2011. PMID: 21900594 Free PMC article.

7

Targeted deletion of LPA5 identifies novel roles for lysophosphatidic acid signaling in development of neuropathic pain.

Lin ME, Rivera RR, Chun J. Lin ME, et al. Among authors: rivera rr. J Biol Chem. 2012 May 18;287(21):17608-17617. doi: 10.1074/jbc.M111.330183. Epub 2012 Mar 29. J Biol Chem. 2012. PMID: 22461625 Free PMC article.

8

Sphingosine 1-phosphate receptors are essential mediators of eyelid closure during embryonic development.

Herr DR, Lee CW, Wang W, Ware A, Rivera R, Chun J. Herr DR, et al. Among authors: rivera r. J Biol Chem. 2013 Oct 11;288(41):29882-9. doi: 10.1074/jbc.M113.510099. Epub 2013 Sep 3. J Biol Chem. 2013. PMID: 24003216 Free PMC article.

9

Lysophosphatidic acid (LPA) and its receptor, LPA1 , influence embryonic schwann cell migration, myelination, and cell-to-axon segregation.

Anliker B, Choi JW, Lin ME, Gardell SE, Rivera RR, Kennedy G, Chun J. Anliker B, et al. Among authors: rivera rr. Glia. 2013 Dec;61(12):2009-22. doi: 10.1002/glia.22572. Epub 2013 Sep 24. Glia. 2013. PMID: 24115248 Free PMC article.

10

Dimethyl fumarate inhibits integrin α4 expression in multiple sclerosis models.

Kihara Y, Groves A, Rivera RR, Chun J. Kihara Y, et al. Among authors: rivera rr. Ann Clin Transl Neurol. 2015 Oct;2(10):978-83. doi: 10.1002/acn3.251. Epub 2015 Sep 11. Ann Clin Transl Neurol. 2015. PMID: 26478898 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

870 results

Search Page